Ransomware Group: CLOP

VICTIM NAME: AMSINO[.]COM

NOTE: No files or stolen information are [exfiltrated/downloaded/taken/hosted/seen/reposted/disclosed] by RedPacket Security. Any legal issues relating to the content of the files should be directed at the attackers directly, not RedPacket Security. This blog is simply posting an editorial news post informing that a company has fallen victim to a ransomware attack. RedPacket Security is in no way affiliated or aligned with any ransomware threat actors or groups and will not host infringing content. The information on this page is fully automated and redacted whilst being scraped directly from the CLOP Onion Dark Web Tor Blog page.

AI Generated Summary of the Ransomware Leak Page

Amsino International Inc., a healthcare-focused company based in the United States, specializes in producing advanced medical devices. The leaked information indicates that Amsino operates in a segment characterized by crucial products such as infusion and syringe pumps, respiratory therapy devices, and enteral feeding solutions, among others. As part of its global strategy, the company aims to improve patient care and healthcare efficiency, servicing over 85 countries. The compromise of data at this level raises serious concerns regarding sensitive health information and the integrity of patient care systems associated with their products.

The ransomware leak page detailing Amsino International Inc. was discovered on February 10, 2025, highlighting its importance in both cybersecurity and the healthcare industry. The page likely contains evidence of data breaches, including potential leaks of proprietary information or internal documents. The presence of a screenshot from the leak further emphasizes the gravity of the situation, as such images can illustrate the compromised data’s extent and impact. Additionally, the page notes that various links to downloadable content may be available, adding to the risk faced by the company and its clients. The ramifications of this incident could significantly affect their operations and reputation within the medical devices market.